Cancer Health Treatment Update Study Hints at Mediterranean Diet Slowing Prostate Cancer Progression Men who most closely followed the Mediterranean diet had a lower risk of progression. Dr. James Allison on the Path to More Effective Immunotherapies The Nobel Prize winner continues to search for more immune checkpoints that can be blocked. Many Immunotherapy Recipients Experience Persistent Adverse Events However, a majority of these chronic immune-related side effects were mild. Confronting Racism to Improve Cancer Care Health equity advocate Karen Winkfield, MD, MPH, works to enroll more underserved people with cancer in lifesaving clinical trials. Advertisement T Cells Recognize Recent SARS-CoV-2 Variants Research suggests protective effect of natural infection or vaccination is likely to be persistent. More News About COVID-19 For more news about the novel coronavirus and COVID-19, including how it affects people living with cancer, visit our sister site, COVID Health.com. Cancer Health Spring 2021 Check out our latest print edition! Newsfeed World Health Day 2021 [VIDEO] Applying Sunscreen à La Gwyneth Paltrow Could Put You at Risk for Skin Cancer Study Hints at Mediterranean Diet Slowing Prostate Cancer Progression Two New Studies Suggest Diet Can Help Breast Cancer Survivors Live Longer Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Follicular Lymphoma FDA Approves Lorbrena for Metastatic ALK-Positive Lung Cancer FDA Approved Pepaxto for Heavily Treated Multiple Myeloma FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy Newsfeed World Health Day 2021 [VIDEO] Applying Sunscreen à La Gwyneth Paltrow Could Put You at Risk for Skin Cancer Study Hints at Mediterranean Diet Slowing Prostate Cancer Progression Two New Studies Suggest Diet Can Help Breast Cancer Survivors Live Longer Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Follicular Lymphoma FDA Approves Lorbrena for Metastatic ALK-Positive Lung Cancer FDA Approved Pepaxto for Heavily Treated Multiple Myeloma FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: